The basal cell carcinoma (BCC) treatment market is shaped by the high incidence of this slow-growing, sun-exposure–linked skin cancer and the wide range of clinical presentations—from superficial lesions to locally advanced disease. First-line care is typically procedure-based, with surgical excision and Mohs micrographic surgery favored for higher-risk, facial, or recurrent tumors du... https://www.oganalysis.com/industry-reports/basal-cell-carcinoma-treatment-market